Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19<blockquote>吉利德的瑞德西韦在患有严重 COVID-19 高风险合并症的患者中显示出一致的疗效</blockquote>
China stocks listed in US gained in early trading, with BILI, XPeng, NetEase and iQiyi rising between 6% and 9%.<blockquote>在美国上市的中国股票早盘上涨,比利、小鹏、网易和爱奇艺上涨6%至9%。</blockquote>